Wolseley PLC
16 June 2006
Wolseley plc hereby confirms the following share purchases made under the
dividend reinvestment arrangements for shares held in ADRs under the US Employee
Share Purchase Plan of which notification was received from the Plan
administrator yesterday:
Director's Name No. of ADRs purchased Purchase price per ADR in US$
------------------------------------------------------------------------------
Charles A Banks 4.389 41.857647
Fenton N Hord 4.389 41.857647
Claude A S Hornsby 4.389 41.857647
Robert H Marchbank 4.391 41.857647
Frank W Roach 4.392 41.857647
The directors' beneficial holdings have each been respectively increased as a
result of these purchases.
Note: One ADR (American Depositary Receipt) currently comprises two ordinary
shares of 25p each in the capital of Wolseley plc. As announced earlier today,
the ratio will change to one ADR for every one ordinary share of 25p for ADR
holders registered on 30 June 2006. ADRs are traded on the New York Stock
Exchange.
FURTHER INFORMATION:
Wolseley plc
Tel: 0118 929 8700
Guy Stainer - Head of Investor Relations
Mark White - Group Company Secretary and Counsel
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.